PROSTATE CANCER WITH PSA GRAY ZONE

Clinical trials for PROSTATE CANCER WITH PSA GRAY ZONE explained in plain language.

Never miss a new study

Get alerted when new PROSTATE CANCER WITH PSA GRAY ZONE trials appear

Sign up with your email to follow new studies for PROSTATE CANCER WITH PSA GRAY ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

AI could slash unnecessary prostate biopsies in 'Gray Zone' patients

Diagnosis Ongoing

This study tests an artificial intelligence system that combines blood tests, lab data, and ultrasound images to better diagnose prostate cancer in men with borderline PSA levels (4-10 ng/mL). The goal is to reduce unnecessary biopsies by accurately identifying who truly has canc…

Matched conditions: PROSTATE CANCER WITH PSA GRAY ZONE

Sponsor: Guangxi Medical University • Aim: Diagnosis

Last updated Jun 27, 2026 14:00 UTC

PROSTATE CANCER WITH PSA GRAY ZONE

Get alerted when new PROSTATE CANCER WITH PSA GRAY ZONE trials appear

AI could slash unnecessary prostate biopsies in 'Gray Zone' patients